24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular Dystrophy
PLoS ONE2013Vol. 8(1), pp. e52512–e52512
Citations Over TimeTop 10% of 2013 papers
Elena Mazzone, Marika Pane, Maria Pia Sormani, Roberta Scalise, Angela Berardinelli, Sonia Messina, Yvan Torrente, Adele D’Amico, Luca Doglio, Emanuela Viggiano, Paola D′Ambrosio, Filippo Cavallaro, Silvia Frosini, Luca Bello, S Bonfiglio, Roberto De Sanctis, Enrica Rolle, Flaviana Bianco, Francesca Magri, Francesca Rossi, Gessica Vasco, Gian Luca Vita, Maria Chiara Motta, Maria Alice Donati, Michele Sacchini, Tiziana Mongini, Antonella Pini, Roberta Battini, Elena Pegoraro, Stefano C. Previtali, Sara Napolitano, Claudio Bruno, Luisa Politano, Giacomo P. Comi, Enrico Bertini, Eugenio Mercuri
Abstract
These results can be of help at the time of using inclusion criteria for a study in ambulant patients in order to minimize the risk of patients who may lose ambulation within the time of the trial.
Related Papers
- → Physical Activity in Boys With Duchenne Muscular Dystrophy Is Lower and Less Demanding Compared to Healthy Boys(2017)38 cited
- → Reversal of cardiac and skeletal manifestations of Duchenne muscular dystrophy by cardiosphere-derived cells and their exosomes in mdx dystrophic mice and in human Duchenne cardiomyocytes(2017)9 cited
- → Enhanced urinary spontaneous luminescence in duchenne muscular dystrophy(1994)7 cited
- → VP.85 C-Path's Duchenne Regulatory Science Consortium: Accelerating drug development for Duchenne muscular dystrophy(2022)
- → Design of a phase 2 clinical program for the development of PGN-EDO51 in participants with duchenne muscular dystrophy (DMD)(2023)